Mondrian Investment Partners LTD Takeda Pharmaceutical CO LTD Transaction History
Mondrian Investment Partners LTD
- $6.79 Billion
- Q1 2024
A detailed history of Mondrian Investment Partners LTD transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Mondrian Investment Partners LTD holds 12,079,962 shares of TAK stock, worth $156 Million. This represents 2.47% of its overall portfolio holdings.
Number of Shares
12,079,962
Previous 8,167,393
47.9%
Holding current value
$156 Million
Previous $117 Million
43.97%
% of portfolio
2.47%
Previous 2.0%
Shares
17 transactions
Others Institutions Holding TAK
# of Institutions
341Shares Held
76MCall Options Held
1.85MPut Options Held
121K-
Capital Research Global Investors Los Angeles, CA13.1MShares$170 Million0.04% of portfolio
-
Morgan Stanley New York, NY5MShares$64.6 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY4.21MShares$54.5 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.12MShares$40.3 Million0.07% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA2.9MShares$37.6 Million0.54% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $40.2B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...